Amyotrophic lateral sclerosis mortality rates in Chile: A population based study (1994-2010)

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 16, Issue 5-6, 2015, Pages 372-377

  Valenzuela, Daniel ^a,b   Zitko, Pedro ^b,c   Lillo, Patricia ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL BARROS LUCO TRUDEAU   (Chile)

^c UNIVERSIDAD DIEGO PORTALES   (Chile)

Author keywords

Amyotrophic lateral sclerosis; mortality rates; motor neuron disease

Indexed keywords

ADULT; AGE; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAUSE OF DEATH; CHILE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPEAN; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MOTOR NEURON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; VERY ELDERLY; AGE DISTRIBUTION; HEALTH CARE PLANNING; METABOLISM; STATISTICAL MODEL; SURVIVAL ANALYSIS; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; CHILE; COHORT STUDIES; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84945133508     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2015.1026827     Document Type: Article

References (40)

1. Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010; 81: 385-90.
2. Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68: 1002-7.
3. Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009; 72: 1640-5.
4. Bettini M, Vicens J, Giunta DH, Rugiero M, Cristiano E. Incidence and prevalence of amyotrophic lateral sclerosis in an HMO of Buenos Aires, Argentina. Amyotroph Lateral Scler Frontotemporal Degener. 2013; 14: 598-603.
5. Bucheli M, Andino A, Montalvo M, Cruz J, Atassi N, Berry J, et al. Amyotrophic lateral sclerosis: analysis of ALS cases in a predominantly admixed population of Ecuador. Amyotroph Lateral Scler Frontotemporal Degener. 2014; 15: 106-13.
6. Matos SE, Conde MT, Favero FM, Taniguchi M, Quadros AA, Fontes SV, et al. Mortality rates due to amyotrophic lateral sclerosis in Sao Paulo City from 2002 to 2006. Arquivos de Neuro-Psiquiatria.2011; 69: 861-6.
7. Veiga-Cabo J, Almazan-Isla J, Sendra-Gutierrez JM, de Pedro-Cuesta J. Differential features of motor neuron disease mortality in Spain. International Journal of Epidemiology. 1997; 26: 1024-32.
8. Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013; 41: 118-30.
9. Vazquez MC, Ketzoian C, Legnani C, Rega I, Sanchez N, Perna A, et al. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study. Neuroepidemiology. 2008; 30: 105-11.
10. Okamoto K, Kobashi G, Washio M, Sasaki S, Yokoyama T, Miyake Y, et al. Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001. Journal of Epidemiology/ Japan Epidemiological Association. 2005; 15: 20-3.
11. Galdames D, Aguilera L, Riveros JM, Arce C. Epidemiology of amyotrophic lateral sclerosis in Santiago: a retrospective study (authors transl). Revista medica de Chile. 1980; 108: 435-9.
12. Fuentes M, Pulgar I, Gallo C, Bortolini MC, Canizales-Quinteros S, Bedoya G, et al. Gene geography of Chile: regional distribution of American, European and African genetic contributions. Revista medica de Chile. 2014; 142: 281-9.
13. Kondo K, Tsubaki T. Changing mortality patterns of motor neuron disease in Japan. Journal of the Neurological Sciences. 1977; 32: 411-24.
14. Dean G, Quigley M, Goldacre M. Motor neuron disease in a defined English population: estimates of incidence and mortality. J Neurol Neurosurg Psychiatry. 1994; 57: 450-4.
15. Buckley J, Warlow C, Smith P, Hilton-Jones D, Irvine S, Tew JR. Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry. 1983; 46: 197-205.
16. Chancellor AM, Warlow CP. Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950. J Neurol Neurosurg Psychiatry. 1992; 55: 1106-15.
17. Chio A, Magnani C, Schiffer D. Gompertzian analysis of amyotrophic lateral sclerosis mortality in Italy, 1957-1987; application to birth cohorts. Neuroepidemiology. 1995; 14: 269-77.
18. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008; 79: 6-11.
19. Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation. Journal of Neurology. 1994; 241: 448-55.
20. Flaten TP. Rising mortality from motor neuron disease. Lancet. 1989; 1: 1018-9.
21. Stickler DE, Royer JA, Hardin JW. Validity of hospital discharge data for identifying cases of amyotrophic lateral sclerosis. Muscle & Nerve. 2011; 44: 814-6.
22. Nunez FM, Icaza NM. Quality of Mortality Statistics in Chile, 1997-2003. Revista medica de Chile. 2006; 134: 1191-6.
23. Omar B, Ahmad CB-P, Lopez AD, Murray CJL, Rafael LR, Inoue M. Age standardization of rates: a new WHO standard. http://www.who.int/healthinfo/paper31.pdf: World Health Organization; 2001.
24. Chio A, Ciccone G, Calvo A, Vercellino M, Di Vito N, Ghiglione P, et al. Validity of hospital morbidity records for amyotrophic lateral sclerosis: a population based study. Journal of Clinical Epidemiology. 2002; 55: 723-7.
25. Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology. 2005; 25: 144-52.
26. INE. XVII Censos de Población 2002. Instituto Nacional de Estadística INE. Santiago, Chile. 2002.
27. Cruz-Coke R, Moreno RS. Genetic epidemiology of single gene defects in Chile. Journal of Medical Genetics. 1994; 31: 702-6.
28. Guillou M, Carabantes CJ, Bustos FV. Availability of physicians and specialists in Chile. Revista medica de Chile. 2011; 139: 559-70.
29. Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003; 60: 683-9.
30. Scott KM, Abhinav K, Wijesekera L, Ganesalingam J, Goldstein LH, Janssen A, et al. The association between ALS and population density: a population based study. Amyotrophic lateral sclerosis: official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases. 2010; 11: 435-8.
31. Trojsi F, Monsurro MR, Tedeschi G. Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives. International Journal of Molecular Sciences. 2013; 14: 15286-311.
32. Chio A. Risk factors in the early diagnosis of ALS: European epidemiological studies. Amyotrophic lateral sclerosis and other motor neuron disorders: official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases. 2000; 1 (Suppl 1): S13-8.
33. Cellura E, Spataro R, Taiello AC, La Bella V. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis. Clinical Neurology and Neurosurgery. 2012; 114: 550-4.
34. Durrleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology. 1989; 39: 768-73.
35. Chio A, Magnani C, Schiffer D. Amyotrophic lateral sclerosis mortality in Italy, 1958-1987: a cross-sectional and cohort study. Neurology. 1993; 43: 927-30.
36. Gunnarsson LG, Lindberg G, Soderfelt B, Axelson O. The mortality of motor neuron disease in Sweden. Archives of Neurology. 1990; 47: 42-6.
37. Jorge S. Reseña de la salud pública materno-infantil chilena durante los últimos 40 años: 1960-2000. Rev Chil Obstet Ginecol. 2002; 67: 129-35.
38. Medina E, Kaempffer AM. Adult mortality in Chile. Revista medica de Chile. 2000; 128: 1144-9.
39. Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology. 2011; 36: 29-38.
40. Bostrom I, Riise T, Landtblom AM. Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden. Neuroepidemiology. 2012; 38: 245-9.